title: Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells.
abstract: Nearly 60 years ago Otto Warburg proposed, in a seminal publication, that an irreparable defect in the oxidative capacity of normal cells supported the switch to glycolysis for energy generation and the appearance of the malignant phenotype (Warburg, 1956). Curiously, this phenotype was also observed by Warburg in embryonic tissues, and recent research demonstrated that normal stem cells may indeed rely on aerobic glycolysis - fermenting pyruvate to lactate in the presence of ample oxygen - rather than on the complete oxidation of pyruvate in the Krebs cycle - to generate cellular energy (Folmes et al., 2012). However, it remains to be determined whether this phenotype is causative for neoplastic development, or rather the result of malignant transformation. In addition, in light of mounting evidence demonstrating that cancer cells can carry out electron transport and oxidative phosphorylation, although in some cases predominantly using electrons from non-glucose carbon sources (Bloch-Frankenthal et al., 1965), Warburg's hypothesis needs to be revisited. Lastly, recent evidence suggests that the leukemia bone marrow microenvironment promotes the Warburg phenotype adding another layer of complexity to the study of metabolism in hematological malignancies. In this review we will discuss some of the evidence for alterations in the intermediary metabolism of leukemia cells and present evidence for a concept put forth decades ago by lipid biochemist Feodor Lynen, and acknowledged by Warburg himself, that cancer cell mitochondria uncouple ATP synthesis from electron transport and therefore depend on glycolysis to meet their energy demands (Lynen, 1951; Warburg, 1956).
authors.affiliation: Grupo de Terapia Celular y Molecular Laboratorio de Bioquimica, Pontificia Universidad Javeriana Bogotá, Colombia.
authors.forename: Juliana
authors.initials: J
authors.lastname: Vélez
authors.forename: Numsen
authors.initials: N
authors.lastname: Hail
authors.forename: Marina
authors.initials: M
authors.lastname: Konopleva
authors.forename: Zhihong
authors.initials: Z
authors.lastname: Zeng
authors.forename: Kensuke
authors.initials: K
authors.lastname: Kojima
authors.forename: Ismael
authors.initials: I
authors.lastname: Samudio
authors.forename: Michael
authors.initials: M
authors.lastname: Andreeff
keywords: Krebs cycle; OXPHOS; anaplerosis; apoptosis; cataplerosis; electron transport; microenvironment; mitochondrial uncoupling
references.citation: Biochem J. 1937 May;31(5):772-9
references.pmid: 16746397
references.citation: Cancer Res. 2008 Jul 1;68(13):5198-205
references.pmid: 18593920
references.citation: Br J Cancer. 1994 Nov;70(5):857-66
references.pmid: 7947090
references.citation: Haematologia (Budap). 1988;21(2):109-14
references.pmid: 3417182
references.citation: Cell Metab. 2012 Jan 4;15(1):110-21
references.pmid: 22225880
references.citation: Int Rev Cytol. 2000;192:189-221
references.pmid: 10553280
references.citation: Biochem J. 1938 Jan;32(1):113-7
references.pmid: 16746585
references.citation: Cell Stem Cell. 2013 Mar 7;12(3):329-41
references.pmid: 23333149
references.citation: J Biol Chem. 1998 Aug 21;273(34):21682-91
references.pmid: 9705303
references.citation: Adv Exp Med Biol. 1991;309A:361-4
references.pmid: 1789244
references.citation: Leukemia. 2008 Mar;22(3):635-8
references.pmid: 17805332
references.citation: Apoptosis. 1999 Apr;4(2):81-7
references.pmid: 14634285
references.citation: Apoptosis. 2010 Oct;15(10):1234-46
references.pmid: 20544286
references.citation: Cancer Res. 2008 Apr 15;68(8):2813-9
references.pmid: 18413749
references.citation: J Biol Chem. 1975 Jun 10;250(11):4322-6
references.pmid: 165196
references.citation: Nature. 2011 Nov 20;481(7381):380-4
references.pmid: 22101433
references.citation: Biochem Pharmacol. 1996 Aug 23;52(4):527-34
references.pmid: 8759024
references.citation: Cancer Cell. 2007 Jan;11(1):37-51
references.pmid: 17222789
references.citation: Free Radic Biol Med. 2010 Dec 15;49(12):2001-9
references.pmid: 20923701
references.citation: PLoS One. 2011 May 04;6(5):e19645
references.pmid: 21573193
references.citation: Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1225-30
references.pmid: 20381449
references.citation: IUBMB Life. 2001 Sep-Nov;52(3-5):159-64
references.pmid: 11798028
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
references.pmid: 18032601
references.citation: Curr Opin Clin Nutr Metab Care. 2007 Nov;10(6):664-70
references.pmid: 18089945
references.citation: Regul Pept. 2009 Jun 5;155(1-3):62-9
references.pmid: 19289146
references.citation: Cancer Res. 1972 Oct;32(10):2007-16
references.pmid: 4343003
references.citation: Antioxid Redox Signal. 2010 Sep 15;13(6):807-19
references.pmid: 20367277
references.citation: J Immunol. 2007 Nov 15;179(10):6479-84
references.pmid: 17982036
references.citation: PLoS One. 2008 Mar 19;3(3):e1852
references.pmid: 18350175
references.citation: J Biol Chem. 2004 Aug 6;279(32):33035-8
references.pmid: 15096496
references.citation: Exp Cell Res. 1989 Jun;182(2):673-80
references.pmid: 2721599
references.citation: Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G1017-24
references.pmid: 18292186
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1490-501
references.pmid: 11009433
references.citation: J Biol Chem. 2008 May 9;283(19):13482-90
references.pmid: 18308720
references.citation: J Biol Chem. 2011 Dec 9;286(49):42626-42634
references.pmid: 21998308
references.citation: Cancer Res. 2009 Mar 15;69(6):2163-6
references.pmid: 19258498
references.citation: Free Radic Biol Med. 2012 Jan 15;52(2):410-9
references.pmid: 22115789
references.citation: PLoS One. 2011;6(8):e23108
references.pmid: 21853076
references.citation: Leukemia. 2002 Sep;16(9):1713-24
references.pmid: 12200686
references.citation: Biochim Biophys Acta. 2009 May;1787(5):553-60
references.pmid: 19285479
references.citation: Mol Cell Biol. 2004 Jan;24(2):730-40
references.pmid: 14701745
references.citation: Mitochondrion. 2012 Jan;12(1):24-34
references.pmid: 21530686
references.citation: Free Radic Biol Med. 2000 Apr 15;28(8):1206-13
references.pmid: 10889450
references.citation: Cell Metab. 2011 Sep 7;14(3):285-6
references.pmid: 21907134
references.citation: Clin Cancer Res. 1997 Jul;3(7):1167-77
references.pmid: 9815796
references.citation: Mol Cell Biochem. 1994 Nov 9;140(1):1-22
references.pmid: 7877593
references.citation: Mol Aspects Med. 2010 Jun;31(3):227-85
references.pmid: 20346371
references.citation: J Clin Invest. 2010 Jan;120(1):142-56
references.pmid: 20038799
references.citation: Blood. 2009 Feb 12;113(7):1504-12
references.pmid: 18957686
references.citation: Mol Nutr Food Res. 2009 Jan;53(1):49-67
references.pmid: 19051186
references.citation: Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6
references.pmid: 22106302
references.citation: Cancer Res. 1965 Jun;25:732-6
references.pmid: 14347561
references.citation: Cell Stem Cell. 2012 Nov 2;11(5):596-606
references.pmid: 23122287
references.citation: Exp Cell Res. 2001 Jan 15;262(2):170-9
references.pmid: 11139341
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: Mol Cell. 2004 Dec 3;16(5):819-30
references.pmid: 15574336